Mary D Chamberlin

8PUBLICATIONS
67CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersCommunication studiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 26, 2026
Referral Patterns and Delays in the Care of Patients With Breast Complaints in Rwanda: A Cohort Study From a Tertiary Hospital.

Vincent Kwizera, Benitha Rangira, Brandon A Niyibizi

|Jan 08, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.

Steven Tau, Mary D Chamberlin, Huijuan Yang

|Sep 21, 2023
Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 Pandemic.

Deborah B Ejem, Stephen Wechsler, Sarah Gallups

|Sep 21, 2023
Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer.

Xu Cao, Kristen E Muller, Mary D Chamberlin

|Jun 01, 2023
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.

Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar

|Oct 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).

Sylvia Adams, Megan Othus, Sandip Pravin Patel

Pageof 2

Frequent Collaborators

2 joint publications

Shannon M Soucy

2 joint publications

Todd W Miller

2 joint publications

Fred W Kolling

2 joint publications

Jonathan D Marotti